Malaria vaccine price agreement could save $50 million
UNICEF and Gavi announced an agreement expected to lower the price of the RTS,S/AS01 malaria vaccine by around 40 percent, potentially saving $50 million from 2027 to 2029.
Editorial summary from primary sourcesEditorial date: Read 2 min
Original editorial illustration, not a photograph of the event. · Arab Brief · Editorial illustration
READING OPTIONS
IN 30 SECONDS
Three key points
UNICEF and Gavi announced an agreement expected to lower the price of the RTS,S/AS01 malaria vaccine by around 40 percent, potentially saving $50 million from 2027 to 2029.
The planned price is EUR 5.
Lower costs could help immunization programmes reach more children, but the agreement is not yet unconditional.
What happened?
UNICEF and Gavi announced an agreement expected to lower the price of the RTS,S/AS01 malaria vaccine by around 40 percent, potentially saving $50 million from 2027 to 2029.
Background
The planned price is EUR 5.50 per dose, subject to regulatory and manufacturing milestones before procurement begins.
Why it matters
Lower costs could help immunization programmes reach more children, but the agreement is not yet unconditional.
What to watch
Monitor the manufacturing and approval steps before treating the savings as realized.
Sources & verification
Prepared from the primary sources below. The original source date is distinct from this edition’s editorial date. Illustrations do not portray real events.
The World Health Organization highlighted its collaboration with K-pop group ENHYPEN in Seoul on 22 October 2026 after a campaign encouraging voluntary blood donation.
